Press Release
FOR IMMEDIATE RELEASE
New Case Study Reveals How Automation is Revolutionizing 24/7 Sobriety and Court-Mandated Alcohol Testing
BILLINGS, MT – A new case study released today by AlcoPro, in partnership with Cannabix Technologies and Freidel Clinic, highlights a significant shift in alcohol monitoring technology, documenting the successful multi-year deployment of the BreathLogix Workplace Series (WS) at the Friedel Clinic. The study illustrates how autonomous, unmanned testing is replacing traditional, labor-intensive methods to provide more reliable and cost-effective compliance.
The Friedel Clinic, which supports high-accountability programs including court-mandated testing and 24/7 sobriety initiatives, reported that the BreathLogix system maintained zero downtime while supporting thousands of tests. By automating the testing process, the clinic eliminated approximately $11,222 in annual recurring costs typically associated with manual staff supervision, disposable mouthpieces, and frequent maintenance of traditional handheld devices.
“The BreathLogix WS is not simply a testing device—it is a compliance platform,” the study concludes. Holding critical regulatory approvals from the NHTSA and DOT, the system provides the “regulatory-grade accuracy and defensibility” required for legal and safety-sensitive environments. The full case study and an operational impact infographic are now available for download at alcopro.com.
BreathLogix Freidel Clinic case study
About AlcoPro
Since 1982, AlcoPro has been a trusted leader in drug and alcohol testing solutions for employers, healthcare professionals, law enforcement, and substance abuse specialists. Known for reliable instruments like market-leading breathalyzers, AlcoPro also offers innovative online training with interactive tools to enhance knowledge retention. With a comprehensive product catalog, easy online ordering, and expert support, AlcoPro makes workplace testing simple, accurate, and professional. Learn more at www.AlcoPro.com.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a developer of marijuana and alcohol breathalyzer technologies for law enforcement, workplaces and laboratories. Cannabix is developing delta-9 THC and alcohol screening devices. Delta-9 THC is the primary psychoactive ingredient in cannabis. Breath testing for delta-9 THC would allow employers and law enforcement to identify recent marijuana use. Cannabix is the developer of its Breath Logix Series of breath alcohol detection devices for employers and a range of other settings.
About Freidel Clinic
Friedel Clinic is a private healthcare provider based in Billings, Montana, focused on advanced diagnostic and therapeutic services that support brain health and overall well-being. The clinic offers personalized treatment programs. In addition to clinical services, Friedel Clinic supports compliance-oriented testing programs, such as court-mandated, probation, treatment monitoring, and 24/7 sobriety programs, leveraging tools like the BreathLogix Workplace Series (WS) to conduct high-volume, reliable alcohol screening and monitoring for legal and treatment populations.